Chris K. Achar

Chris K. Achar is an accomplished healthcare executive, entrepreneur, and investor with extensive experience in the biotech sector. Here are some key details about him:

Professional Background

• Founder and CEO of Genzum Life Sciences, a pharmaceutical product development and out-licensing company1
• Founder of Synergy Ventures, a biotech venture fund that has invested in several health-focused startups
• Former Director and Chief Business Officer at Cue Health Inc.1

Current Roles

• CEO of Genzum Life Sciences1
• Operating Partner at Cue Health, where he leads commercialization efforts for their COVID-19 test
• Investor in various biotech and healthcare companies, including HeartBeam Inc. (NASDAQ: BEAT)

Achievements

• Scaled Genzum Life Sciences from an early-stage R&D firm to a successful enterprise with FDA-approved products
• Co-led Cue Health's Series B financing and joined as a Board Member
• Established strategic partnerships with organizations like Mayo Clinic, the NBA, and Henry Schein Medical

Education

• Undergraduate degree from California State University1
• MBA from Pepperdine Graziadio Business School1

Chris K. Achar has demonstrated a strong track record in healthcare entrepreneurship, investment, and leadership. His experience spans product development, FDA approvals, venture capital, and strategic partnerships in the biotech and healthcare sectors.